“Safe” Plastic Alternatives Linked to Scary Health Problems

<a href="http://www.istockphoto.com/photo/dangerous-water-bottle-10760758?st=8070dd2">wwing</a>/iStock

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Exposure to two chemicals widely considered safe—and used in hundreds of consumer products including plastics, cosmetics, and soap—has been linked to increased blood pressure, insulin resistance, and other dangerous health problems in children, according to a new study.

The chemicals, di-isononyl (DINP) and di-isodecyl (DIDP), were long seen as safer alternatives to their precursor, a phthalate called DEHP, which was associated with hypertension. Even though their use has been on the rise over the past decade, they were never fully tested—until now.

In one study, researchers from the NYU Langone Medical Center analyzed urine samples of over 1,300 adolescents between the ages of 8 and 19 and found that the levels of DINP and DIDP corresponded to levels in blood pressure. In a separate study, the same team studied 356 teens and found a similar correlation between the chemical levels and insulin resistance—a condition that can lead to diabetes.

The researchers recommend limiting exposure to these compounds by avoiding plastics marked with 3, 6, and 7, opting for fresh food over packaged, and making sure never to put plastic containers in the microwave or dishwasher, where they are more apt to leech chemicals.

This isn’t the first time plasticizing chemicals marketed as safe alternatives have proven otherwise. In last year’s Mother Jones investigation into the dangers of BPA-free plastics, Mariah Blake uncovered the plastic industry’s “Big-Tobacco” style campaign to bury research that showed how their products were connected to a litany of health problems—and the US government’s failure to step in:

US regulators also have continued to ignore the mounting evidence linking BPA and similar chemicals to human disease, even as bans have cropped up around the world. Although more than 90 studies examining people with various levels of exposure suggest BPA affects humans much as it does animals, the FDA recently announced that its research “supports the safety of BPA” in food containers and packaging. And the EPA program that was supposed to screen some 80,000 chemicals for endocrine disruption hasn’t fully vetted a single substance. In 2010, the agency sought White House approval to add some endocrine-disrupting chemicals that are commonly found in plastic—among them BPA, phthalates, and a class of compounds known as PBDEs—to its “chemicals of concern” list because it found they “may present an unreasonable risk to human health.” This would have required chemical makers to share safety-testing data with federal regulators. The proposal languished until last September, when the EPA quietly withdrew it, along with a proposed rule requiring manufacturers to disclose safety data on chemicals in their products.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate